Meda AB (MEDAa.ST)

MEDAa.ST on Stockholm Stock Exchange

107.10SEK
10:32am EDT
Price Change (% chg)

-0.30kr (-0.28%)
Prev Close
107.40kr
Open
107.70kr
Day's High
107.70kr
Day's Low
106.80kr
Volume
175,520
Avg. Vol
775,187
52-wk High
129.90kr
52-wk Low
69.70kr

MEDAa.ST

Chart for MEDAa.ST

About

Meda AB is a Sweden-based company active in the specialty pharmaceuticals sector. Its portfolio comprises products in the areas of respiratory, cardiology, pain and inflammation, dermatology, gastroenterology and CNS (central nervous system), as well as a range of over the counter (OTC) products. Its operations are organized in... (more)

Overall

Beta: 0.30
Market Cap (Mil.): kr32,460.90
Shares Outstanding (Mil.): 302.24
Dividend: 2.50
Yield (%): 2.33

Financials

  MEDAa.ST Industry Sector
P/E (TTM): 37.97 35.65 36.07
EPS (TTM): 2.83 -- --
ROI: 3.11 18.91 18.18
ROE: 5.63 19.67 19.05
Search Stocks

Sweden's Meda says it a predator, not prey in drugs industry consolidation

STOCKHOLM - Swedish drugmaker Meda , a recent takeover target of U.S. rival Mylan Inc , said on Wednesday acquisitions could double its size in two years and that it considered itself a predator and not prey in a consolidating pharma industry.

07 May 2014

UPDATE 2-Sweden's Meda says it a predator, not prey in drugs industry consolidation

* Q1 EBITDA 1.010 bln SEK vs forecast 1.018 bln in Reuters poll

07 May 2014

EXECUTIVE VIEW-Meda CEO says company could double size in two years

STOCKHOLM, May 7 - Swedish drug maker Meda , a recent takeover target of U.S. rival Mylan Inc , said it was well placed to make large acquisitions of its own after posting first-quarter profits in line with expectations and maintaining its year forecast.

07 May 2014

BRIEF-Meda CEO: could double size of company within 2 yrs

STOCKHOLM, May 7 - Meda : * CEO says could double size of company through acquisitions within 2 years

07 May 2014

Meda Q1 core profit in line with forecasts, repeats outlook

STOCKHOLM, May 7 - Swedish drug maker Meda , a recent takeover target of U.S. rival Mylan Inc , posted first-quarter profits in line with expectations on Wednesday and repeated its outlook for 2014.

07 May 2014

UPDATE 2-Drugmaker Meda's shares fall back after it snubs new Mylan bid

* Meda board says deal lacks support of biggest shareholder

28 Apr 2014

BRIEF-Meda shares fall 8 percent after rejects new offer from Mylan

STOCKHOLM, April 28 - Meda : * Shares fall 8 percent after says rejects new offer from Mylan to buy

28 Apr 2014

Meda board rejects new Mylan offer

STOCKHOLM - Swedish drugmaker Meda has rejected an improved takeover offer from U.S. generics firm Mylan , saying it was confident in its future as an independent company and its biggest shareholder did not support the bid.

28 Apr 2014

NORDIC STOCKS - Factors to watch on April 28

HELSINKI, April 28 - The following stocks may be affected by newspaper reports and other factors on Monday:

28 Apr 2014

Meda rejects Mylan proposal

STOCKHOLM, April 28 - Swedish drug maker Meda said on Monday it had rejected a new offer from U.S. generics firm Mylan to acquire it.

28 Apr 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Sadif Analytics (Premium)
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics (Premium)
$10.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks